Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
about
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseInequities in Ambulatory Care and the Relationship Between Socioeconomic Status and Respiratory Hospitalizations: A Population-Based Study of a Canadian CityImproving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach.Using machine learning to examine medication adherence thresholds and risk of hospitalization.Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary diseaseA review of the value of innovation in inhalers for COPD and asthma.Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.Adherence and health care costs.Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPDDelivering cost-effective care for COPD in the USA: recent progress and current challenges.Inhaled glycopyrronium bromide: a review of its use in patients with moderate to severe chronic obstructive pulmonary disease.Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease.Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary disease.Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients.The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study.Use of pharmacy records to measure treatment adherence: a critical review of the literature.Why Don't Our Patients with Chronic Obstructive Pulmonary Disease Listen to Us? The Enigma of Nonadherence.Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients.Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD.Tiotropium as part of inhaled polytherapy: adherence and associated health-care utilization.A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom.Pattern and Adherence to Maintenance Medication Use in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease: 2008-2013.Does hospitalization influence patients' medication adherence and community pharmacists' interventions?8th international conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 1.A Pilot Study to Assess Patient Adherence to New Chronic Medications Following the Use of a Novel Adherence Tool and Individualized Counseling.
P2860
Q27000043-42C2033A-65BC-4DF1-89AE-0DD883E9D4EFQ28393964-7286992A-5216-4939-83A0-777A73E9FFFBQ35821928-A3637057-FDEF-427A-8AA1-486E1812C810Q35855191-E1569AA0-9E64-483E-A26D-2779D0B21DB2Q36286968-D62A18C6-41CE-49C5-8249-297D3CFF70A7Q36594114-CEDF70C7-3056-4E97-B184-3324A4EDD3DCQ36714639-9ADCD369-835D-4043-99A9-39B83589A6F6Q36858219-1BC4E236-3427-44DD-B954-EBFF8667BFA7Q37456602-39F68F79-8164-4F6A-BE8F-80728F2894F3Q37603117-A980366C-4589-4ECD-8914-0B2640982025Q37614090-4F76D11C-AD88-42D7-A5C4-773F44D94CABQ38068458-07EE1810-FB95-487B-BCD8-2AB3B06CCFF8Q38107178-77B120F6-6A56-47B1-93E5-C6FDAE1548C3Q38235191-73967C0A-F9B9-4BE7-8C67-6FC9200806DBQ38284373-5BA2A455-EB80-449F-86BA-93D588C484F7Q38442023-FAFC0165-C146-4092-BD3D-E49C4C554477Q38612107-DBFD5AED-1D83-4F1F-9548-C322D80BFD37Q38819475-7DA74222-8EAD-4A74-9BA2-AE54AFFCB163Q38907501-96D0092D-FA77-4712-815B-A745146E4904Q39663376-24449F0A-DF95-4F75-AFE0-B6F4392A5C0FQ40216408-5E7DBF2D-EAE1-4EE2-84CF-A7E44A67D159Q41835397-A60B6D98-AA29-434D-8A82-8BAC9C1E8885Q47103157-155F9740-A31A-473D-BA47-B319569A959CQ47360909-6606F85E-3405-43F9-B338-229989850E53Q47966525-40A17DDB-C31F-4B1C-B079-A9E73CFC827BQ50601223-CD7C78B2-FF9B-4F36-BAE1-F49192DD8C7BQ51725664-271B700A-B5DC-4343-B3C6-2D868DD1A30BQ52599392-7FA9BE1A-AA96-47D2-ACBD-FEA625446BF8Q54561788-2B5080CD-BE74-405A-A36B-826F7D245442Q55054583-B6CE0B86-95CC-4022-A4BF-A6C45B2D5146Q55208894-98999D8C-E536-4428-A48E-170F5E388C83
P2860
Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Association of chronic obstruc ...... ding in a Medicare population.
@en
Association of chronic obstruc ...... ding in a Medicare population.
@nl
type
label
Association of chronic obstruc ...... ding in a Medicare population.
@en
Association of chronic obstruc ...... ding in a Medicare population.
@nl
prefLabel
Association of chronic obstruc ...... ding in a Medicare population.
@en
Association of chronic obstruc ...... ding in a Medicare population.
@nl
P2093
P1476
Association of chronic obstruc ...... ding in a Medicare population.
@en
P2093
Anand A Dalal
Bruce Stuart
Ilene H Zuckerman
Jingjing Qian
Lynda Bryant-Comstock
Thomas Shaffer
Yu-Jung Wei
P304
P356
10.1016/J.AMJOPHARM.2012.04.002
P577
2012-04-21T00:00:00Z